Results 241 to 250 of about 975,760 (305)

Redefining CHI3L1: Therapeutic Opportunities at the Crossroads of Immune Suppression and Disease Progression

open access: yesMedicinal Research Reviews, Volume 46, Issue 6, Page 1897-1921, November 2026.
ABSTRACT Chitinase‐3‐like‐1 (CHI3L1, also known as YKL‐40) has been recognized as a biomarker of inflammation and tissue remodeling and has now emerged as a pseudoenzymatic immune checkpoint. Recent structural, immunological, and translational studies redefine it as an active regulator of immune suppression rather than a passive disease marker. Despite
Kirti Upmanyu   +2 more
wiley   +1 more source

Interferon-γ-response to mycobacterial glycopeptidolipids in patients with pulmonary non-tuberculous mycobacterial infection. [PDF]

open access: yesMed Microbiol Immunol
Steindor M   +10 more
europepmc   +1 more source

Cerebral Manifestation of Miliary Tuberculosis Mimicking a Parasitic CNS Infection. [PDF]

open access: yesCase Rep Neurol Med
Martens D   +6 more
europepmc   +1 more source

Coinfections With Respiratory Syncytial Virus in a Cohort of Adults With High‐Risk Conditions, 2015–2020: A Retrospective Observational Study

open access: yes
Health Science Reports, Volume 9, Issue 11, November 2026.
Oluwakemi D. Alonge   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy